// App-Quantinova.ai

3563 : Increased neutrophil infiltration and lower prevalence of tumor mutation burden and microsatellite instability are hallmarks of RAS mutant colorectal cancers.

Researchers

Presenter

  • Yasmine Baca

Principal Investigators

  • Joanne Xiu

  • Andrew Nelson

  • Subbaya Subramanian

  • Mohamed E. Salem

  • Muhammad Shaalan Beg

  • Elisa Fontana

  • Maria Diab

  • Philip Agop Philip

  • Richard M. Goldberg

  • Ritu Pandey

  • Tobias Arkenau

  • Weijing Sun

  • Heinz-Josef Lenz

  • Anthony Frank Shields

  • Wafik S. El-Deiry

  • Wolfgang Michael Korn

  • Emil Lou

Medical Centers

  • Caris Life Sciences, Phoenix, AZ

  • University of Minnesota School of Public Health, Minneapolis, MN

  • University of Minnesota, Minneapolis, MN

  • Levine Cancer Institute, Atrium Health, Charlotte, NC

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • Sarah Cannon Research Institute, London, United Kingdom

  • NCRI, London, United Kingdom

  • Emory University, Atlanta, GA

  • Karmanos Cancer Institute, Detroit, MI

  • West Virginia University Cancer Institute, Morgantown, WV

  • Arizona Cancer Center, Tucson, AZ

  • Sarah Cannon Research Institute, London, United Kingdom

  • University of Kansas Medical Center, Kansas City, MO

  • USC Norris Comprehensive Cancer Center, Los Angeles, CA

  • Karmanos Cancer Institute, Wayne State University, Detroit, MI

  • Cancer Center at Brown University, Providence, PA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • Cluster of Differentiation 206

  • Microsatellite instability

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved